Tweetovi
- Tweetovi, trenutna stranica.
- Tweetovi i odgovori
- Medijski sadržaj
Blokirali ste korisnika/cu @Sarepta
Jeste li sigurni da želite vidjeti te tweetove? Time nećete deblokirati korisnika/cu @Sarepta
-
Prikvačeni tweet
At
#JPMHC20, SRPT CEO, Doug Ingram, underscored our commitment to advancing precision genetic medicine and#DraggingTomorrowIntoToday for those living with#raredisease.#JPM20pic.twitter.com/YjQtp5WkSp
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re so proud to receive recognition from
@gptw_brasil, naming SRPT Brazil a Great Place to Work. Thank you to the team members who nurture a culture of trust, teamwork and respect.#GPTWCertified Learn about career openings on our SRPT Brazil team: http://bit.ly/30Lch0j pic.twitter.com/xKhVEcIuep
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Thank you to the
@JettFoundation for hosting the#ReadySetJett Family Workshop, where we joined families impacted by#Duchenne to share about our urgent mission to bring therapies to those living with#raredisease.pic.twitter.com/Y30UORy1Vh
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Reminder: Forward looking statements are subject to risks, including those described in our
#JPM20 webcast.http://bit.ly/2R7X1pSHvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Tune in: SRPT CEO, Doug Ingram, presents at the
@JPMorgan#Healthcare Conference at 9:30 am PT/ 12:30 pm ET today: http://bit.ly/2R7X1pS#JPM20pic.twitter.com/X655uqAMih
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are excited to welcome
#biotechnology industry veteran, John C. Martin, Ph.D., to SRPT’s Board of Directors. Learn more: http://bit.ly/2Tk7hy7 pic.twitter.com/VRX9sCC5iU
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Save the date: The SRPT team is headed to San Francisco to present at the 38th Annual
@JPMorgan#Healthcare Conference on Monday, Jan. 13.#JPM20 http://bit.ly/301BGCs pic.twitter.com/LAgogopdpM
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Wishing a
#HappyNewYear to all. In 2019, we welcomed over 300 new team members, advanced our pipeline of over 24 programs, and had the opportunity to meet and learn from inspiring members of the patient communities.pic.twitter.com/xL6oG9qCgo
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Our mission to
#dragtomorrowintotoday on behalf of patients and families drives all we do. SRPT CEO, Doug Ingram, highlights how our agreement with@Roche, helps accelerate our mission for#Duchenne patients. Learn more: http://bit.ly/2sVB8Bw pic.twitter.com/PcrreGSXXs
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
On our SRPT conference call, CEO, Doug Ingram, speaks to the impact our OUS licensing agreement with
@Roche, for our investigational#genetherapy for#Duchenne, will have on our mission to bring therapies to patients faster. Read our press release: http://bit.ly/2sVB8Bw pic.twitter.com/HcACy0leHe
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Listen live: Hear from SPRT leadership regarding our new strategic licensing agreement with
@Roche for SRP-9001, our investigational#genetherapy candidate for#Duchenne#musculardystrophy, in countries outside the US. http://bit.ly/392axDL pic.twitter.com/sYXvLtrp3s
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Treating 100% of Duchenne patients has always been our goal. By partnering with
@Roche, the world’s largest#biotech company, we can get there faster.#dragtomorrowintotoday http://bit.ly/2sVB8Bw pic.twitter.com/fPEvhDdai2
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#BREAKING: Today, we announced a strategic licensing agreement with@Roche for SRP-9001, our investigational#genetherapy candidate for#Duchenne#musculardystophy, in countries outside the US Learn more: http://bit.ly/2sVB8Bw#SRPTpic.twitter.com/i10Ic0gxrX
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We’re at the 33rd annual
@MPSSociety Family Conference in Orlando. We look forward to hearing from families and experts, and sharing about our work to develop a potential treatment for#MPSIIIA, also known as#Sanfilippo syndrome A.pic.twitter.com/G4HjfGepAb
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Recently, we joined the Duchenne community in celebrating the
#FDAapproval of the first newborn screening test kit authorized for#Duchenne#MuscularDystrophy, empowering families with information and potentially early treatment options.https://twitter.com/PerkinElmerNews/status/1206260127172616204 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
This afternoon, tune in to the SRPT Patient Support Program webinar hosted by
@CureDuchenne, to hear from executive director of Patient Services, Dan Madden, about SareptAssist, a patient support program helping families navigate the process of starting and staying on therapy.https://twitter.com/CureDuchenne/status/1206618477772992512 …Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
Another milestone for patients and families: We are thrilled to announce FDA approval of a treatment for a subset of patients with
#Duchenne. We remain dedicated to finding treatments for all people living with Duchenne. Read our official announcement: http://bit.ly/2PgcdBx pic.twitter.com/PWBrQCqXqJ
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#Breaking: US FDA approves new treatment for certain patients with#Duchenne#MuscularDystrophy. This approval is an important milestone that reflects our dedication to finding treatments for all people living with Duchenne. http://bit.ly/2PgcdBx pic.twitter.com/u2so5ZtcwF
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
#RaisingAwareness: Each year, Jonathon films a video of himself singing, this year dedicating his performance to those who have lost their lives to#Duchenne. Help him reach his goal of 20,000 shares before Christmas Day: http://bit.ly/2RHQowd pic.twitter.com/lKflHsFjYq
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi -
We are beyond excited to welcome this group to the SRPT team and can’t wait to see all they will accomplish!
#returntoworkhttps://twitter.com/reacHIRE/status/1201548870909603840 …
Hvala. Twitter će to iskoristiti za poboljšanje vaše vremenske crte. PoništiPoništi
Čini se da učitavanje traje već neko vrijeme.
Twitter je možda preopterećen ili ima kratkotrajnih poteškoća u radu. Pokušajte ponovno ili potražite dodatne informacije u odjeljku Status Twittera.